François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Focus op immuuntherapie en targeted agents bij 23ste Nationale Longkankersymposium
feb 2022 | Immuuntherapie, Longoncologie, Mesothelioom